![]() |
GeNeuro: '. . . research antibodies to block pHERV-K Env . . . '
GeNeuro: Cash Position at 31 December 2018 and Business Review
GeNeuro: Cash Position at 31 December 2 18 and Business Review | Business Wire This small company is exploring the neuroprotective value of antibodies in amyotrophic lateral sclerosis. |
All times are GMT -5. The time now is 01:40 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.